Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1993 1
1995 1
1997 1
2001 1
2002 1
2004 2
2005 1
2006 1
2010 1
2011 1
2012 2
2014 1
2015 5
2016 5
2017 4
2018 3
2019 1
2020 3
2021 2
2022 2
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
Salmanton-García J, Marchesi F, Koehler P, Weinbergerová B, Čolović N, Falces-Romero I, Buquicchio C, Farina F, van Praet J, Biernat MM, Itri F, Prezioso L, Tascini C, Vena A, Romano A, Delia M, Dávila-Valls J, Martín-Pérez S, Lavilla-Rubira E, Adžić-Vukičević T, García-Bordallo D, López-García A, Criscuolo M, Petzer V, Fracchiolla NS, Espigado I, Sili U, Meers S, Erben N, Cattaneo C, Tragiannidis A, Gavriilaki E, Schönlein M, Mitrovic M, Pantic N, Merelli M, Labrador J, Hernández-Rivas JÁ, Glenthøj A, Fouquet G, Del Principe MI, Dargenio M, Calbacho M, Besson C, Kohn M, Gräfe S, Hersby DS, Arellano E, Çolak GM, Wolf D, Marchetti M, Nordlander A, Blennow O, Cordoba R, Mišković B, Mladenović M, Bavastro M, Limongelli A, Rahimli L, Pagano L, Cornely OA. Salmanton-García J, et al. Int J Antimicrob Agents. 2023 Oct;62(4):106952. doi: 10.1016/j.ijantimicag.2023.106952. Epub 2023 Aug 13. Int J Antimicrob Agents. 2023. PMID: 37582478 Free article.
The clinical spectrum of CASQ1-related myopathy.
Semplicini C, Bertolin C, Bello L, Pantic B, Guidolin F, Vianello S, Catapano F, Colombo I, Moggio M, Gavassini BF, Cenacchi G, Papa V, Previtero M, Calore C, Sorarù G, Minervini G, Tosatto SCE, Stramare R, Pegoraro E. Semplicini C, et al. Neurology. 2018 Oct 23;91(17):e1629-e1641. doi: 10.1212/WNL.0000000000006387. Epub 2018 Sep 26. Neurology. 2018. PMID: 30258016 Free PMC article.
Discriminant Incoherent Component Analysis.
Georgakis C, Panagakis Y, Pantic M. Georgakis C, et al. IEEE Trans Image Process. 2016 May;25(5):2021-34. doi: 10.1109/TIP.2016.2539502. IEEE Trans Image Process. 2016. PMID: 27008268 Free article.
In this paper, the discriminant incoherent component analysis (DICA) is proposed in order to extract low-complexity components, corresponding to facial attributes, which are mutually incoherent among different classes (e.g., identity, expression, and AU activation) from tr …
In this paper, the discriminant incoherent component analysis (DICA) is proposed in order to extract low-complexity components, correspondin …
Search for Dark Matter Particle Interactions with Electron Final States with DarkSide-50.
Agnes P, Albuquerque IFM, Alexander T, Alton AK, Ave M, Back HO, Batignani G, Biery K, Bocci V, Bonivento WM, Bottino B, Bussino S, Cadeddu M, Cadoni M, Calaprice F, Caminata A, Campos MD, Canci N, Caravati M, Cargioli N, Cariello M, Carlini M, Cataudella V, Cavalcante P, Cavuoti S, Chashin S, Chepurnov A, Cicalò C, Covone G, D'Angelo D, Davini S, De Candia A, De Cecco S, De Filippis G, De Rosa G, Derbin AV, Devoto A, D'Incecco M, Dionisi C, Dordei F, Downing M, D'Urso D, Fiorillo G, Franco D, Gabriele F, Galbiati C, Ghiano C, Giganti C, Giovanetti GK, Goretti AM, Grilli di Cortona G, Grobov A, Gromov M, Guan M, Gulino M, Hackett BR, Herner K, Hessel T, Hosseini B, Hubaut F, Hungerford EV, Ianni A, Ippolito V, Keeter K, Kendziora CL, Kimura M, Kochanek I, Korablev D, Korga G, Kubankin A, Kuss M, La Commara M, Lai M, Li X, Lissia M, Longo G, Lychagina O, Machulin IN, Mapelli LP, Mari SM, Maricic J, Messina A, Milincic R, Monroe J, Morrocchi M, Mougeot X, Muratova VN, Musico P, Nozdrina AO, Oleinik A, Ortica F, Pagani L, Pallavicini M, Pandola L, Pantic E, Paoloni E, Pelczar K, Pelliccia N, Piacentini S, Pocar A, Poehlmann DM, Pordes S, Poudel SS, Pralavorio P, Price DD, Ragusa F, R… See abstract for full author list ➔ Agnes P, et al. Phys Rev Lett. 2023 Mar 10;130(10):101002. doi: 10.1103/PhysRevLett.130.101002. Phys Rev Lett. 2023. PMID: 36962032 Free article.
By analyzing the ionization signals, we exclude new parameter space for the dark matter-electron cross section sigma[over ]_{e}, the axioelectric coupling constant g_{Ae}, and the dark photon kinetic mixing parameter kappa. ...
By analyzing the ionization signals, we exclude new parameter space for the dark matter-electron cross section sigma[over ]_{e}, the …
Low Conducted-EMI Single-Phase Boost PFC with Sliding Frequency Modulation.
Akhmetov Z, Abdelraziq M, Pantic Z. Akhmetov Z, et al. Conf Proc (IEEE Appl Power Electron Conf Expo). 2023 Mar;2023:1784-1789. doi: 10.1109/apec43580.2023.10131650. Epub 2023 May 31. Conf Proc (IEEE Appl Power Electron Conf Expo). 2023. PMID: 38545927 Free PMC article.
The proposed boost PFC is compared with a conventional boost PFC operated using Constant Frequency Modulation (CFM) at 120 kHz. Both PFCs are rated for the same nominal power (i.e., 300 W) and output voltage (i.e., 383 V). An analytical loss model is also developed …
The proposed boost PFC is compared with a conventional boost PFC operated using Constant Frequency Modulation (CFM) at 120 kHz. Both PFCs ar …
Dynamic Behavior Analysis via Structured Rank Minimization.
Georgakis C, Panagakis Y, Pantic M. Georgakis C, et al. Int J Comput Vis. 2018;126(2):333-357. doi: 10.1007/s11263-016-0985-3. Epub 2017 Jan 19. Int J Comput Vis. 2018. PMID: 31983807 Free PMC article.
A natural assumption for human behavior modeling is that a continuous-time characterization of behavior is the output of a linear time-invariant system when behavioral cues act as the input (e.g., continuous rather than discrete annotations of dimensional affect). ...
A natural assumption for human behavior modeling is that a continuous-time characterization of behavior is the output of a linear time-invar …
Profiling of microorganism-binding serum antibody specificities in professional athletes.
Minić R, Papić Z, Đorđević B, Michaličkova D, Ilić V, Mathiesen G, Živković I, Pantic V, Dimitrijević L. Minić R, et al. PLoS One. 2018 Sep 25;13(9):e0203665. doi: 10.1371/journal.pone.0203665. eCollection 2018. PLoS One. 2018. PMID: 30252853 Free PMC article.
IgM was found to be the most cross reactive antibody class, Pearson's r = 0.7-0.92, for very distant bacterial species such as Lactobacillus and E. coli.High correlation in IgG levels was found for Gammaproteobacteria and LPS (from E. coli) (r = 0.77 for LPS vs. P. …
IgM was found to be the most cross reactive antibody class, Pearson's r = 0.7-0.92, for very distant bacterial species such as Lactobacillus …
Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy.
Javorniczky NR, Wehrle J, Ihorst G, Hupfer V, Aumann K, Pfeifer D, Niemöller C, Bleul S, Pantic M, Werner M, Duyster J, Finke J, Engelhardt M, von Bubnoff N, Waller CF, Pahl HL, Becker H. Javorniczky NR, et al. Leuk Res. 2020 Nov;98:106454. doi: 10.1016/j.leukres.2020.106454. Epub 2020 Sep 15. Leuk Res. 2020. PMID: 32971364
One patient developed multiple myeloma (MM) and one smoldering MM. Seven of 12 patients analyzed carried mutations (e.g. in ASXL1 or TET2) in addition to those in JAK2 or CALR, and 4 of 10 patients showed aberrant cytogenetics. ...
One patient developed multiple myeloma (MM) and one smoldering MM. Seven of 12 patients analyzed carried mutations (e.g. in ASXL1 or …
The Pt(S-pr-thiosal)2 and BCL1 Leukemia Lymphoma: Antitumor Activity In Vitro and In Vivo.
Silconi ZB, Rosic V, Benazic S, Radosavljevic G, Mijajlovic M, Pantic J, Ratkovic ZR, Radic G, Arsenijevic A, Milovanovic M, Arsenijevic N, Milovanovic J. Silconi ZB, et al. Int J Mol Sci. 2022 Jul 24;23(15):8161. doi: 10.3390/ijms23158161. Int J Mol Sci. 2022. PMID: 35897737 Free PMC article.
Treatment of BCL1 cells with PtCl2(S-pr-thiosal)2 inhibited expression of cyclin D3 and cyclin E and enhanced expression of cyclin-dependent kinase inhibitors p16, p21, and p27 resulting in cell cycle arrest in the G1 phase, reduced the percentage of BCL1 cells in the S ph …
Treatment of BCL1 cells with PtCl2(S-pr-thiosal)2 inhibited expression of cyclin D3 and cyclin E and enhanced expression of cyclin-de …
45 results